Regeneron Pharmaceuticals, Inc. · Tarrytown, NY United States (NASDAQ: REGN)
| 777 Old Saw Mill River Rd. | Phone: 914-345-7400 |
| Tarrytown, NY | Fax: 914-347-2113 |
| 10591 | |
| United States | 
Map This Company |
Regeneron Pharmaceuticals, Inc. Rankings
| S&P 400 |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Regeneron isn't the Pentagon, but the company is fighting some serious enemies. Regeneron Pharmaceuticals develops protein-based drugs used to battle a variety of diseases and conditions, including cancer, inflammatory ailments, and eye diseases. The biotechnology company's first commercialized product is ARCALYST, a treatment for rare inflammatory diseases including Muckle-Wells Syndrome. Regeneron also collaborates with
Regeneron Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: REGN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 1,704 |
Executives
93 executives listed for Regeneron Pharmaceuticals, Inc.'s Tarrytown, NY location.
| Chairman | P. Roy Vagelos | |
|---|---|---|
| President, CEO, and Director | Leonard Schleifer | |
| SVP Finance and Administration, CFO, Assistant Secretary, and Treasurer | Murray Goldberg |